Difficult choices and a solid thank you to all
22 November 2024PLEASE SHARE PUBLICLY
It’s taken a while to process the news and again this week another bunch of information and advice to digest. Confirmed relapse!
My appointment yesterday with my Specialist made it abundantly clear. There is two options; move to Aussie and start your life again there to have the funded drug Daratumamab for your best chance of survival or pay for private care here in New Zealand and self fund the drug. Including specialist fees, clinical fees and the drug itself, I am told by my specialist team this is around $175,000. A very real and recent figure that a person recently in my situation has paid.
Every day it frustrates me, frustrates my family, frustrates those who I share my story with, that in what we consider a developed country, we have to battle and suffer the consequences of bureaucracy, that is within a government department (Pharmac). Pharmac clearly lost its sense of strategic direction and mandate. Daratumumab has been in application and under consideration by Pharmac since 2017. Fast forward nearly 8 years and still no resolution.
Every time Pharmac is questioned on the matter, their moral obligation is fulfilled behind the guise of their media team. The same answer, the same tag line, same commercial strategy statement, just a different date at the top.
We believe it is time to expect some accountability and expect answers, real answers from real people. Most of all, we all expect results.
Less Hui more Doey!
Love from our fam
-
Words fail me, mate 😢😢. And you know that's unusual!
I've spread the word.
Love and best wishes.